Second year proceeds granted following FDA review of annual performance progress report on Phase 3 SELVA single-arm, baseline ...
Although rapamycin eventually became a billion-dollar drug, many of the people instrumental to its discovery—most importantly ...
Discover the untold story behind the discovery of rapamycin on Easter Island, raising questions about Indigenous rights and ...
A recent study conducted by researchers at Queen Mary University of London unveiled a new mechanism through which cells ...
A new research paper was published in Volume 17, Issue 8 of Aging-US on August 7, 2025, titled, “What is the clinical ...
ScienceAlert on MSN
A New Class of Drug Created That Fights Aging on a Cellular Level
Researchers from Queen Mary University of London have been testing a new drug called Rapalink-1, building on an existing ...
Endurance exercise may train the immune system as much as the muscles. Older adults with decades of running or cycling had ...
Second year proceeds granted following FDA review of annual performance progress report on Phase 3 SELVA single-arm, baseline-controlled trial; up to $2.6 million in non-dilutive funding anticipated ...
WAYNE, Pa., Sept. 24, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel ...
At the heart of rapamycin’s power lies its ability to inhibit a protein called the target of rapamycin kinase, or TOR. This protein acts as a master regulator of cell growth and metabolism. Together ...
In addition to strengthening the muscles, lungs, and heart, regular physical exercise also strengthens the immune system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback